Want to see NAGE full AI Analyst Report?
Niagen Bioscience (NAGE) Income Statement
Niagen Bioscience Income Statement
Last quarter (Q2 2026), Niagen Bioscience's total revenue was $29.79M, a decrease of 4.28% from the same quarter last year. In Q2, Niagen Bioscience's net income was $963.00K. See Niagen Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 129.42M | $ 99.60M | $ 83.57M | $ 72.05M | $ 67.45M | |
| $ 83.19M | $ 61.59M | $ 50.78M | $ 42.80M | $ 41.49M | |
| $ 68.89M | $ 53.86M | $ 56.38M | $ 61.42M | $ 68.56M | |
| Depreciation and Amortization | $ 1.45M | $ 1.48M | $ 1.71M | $ 1.88M | $ 1.63M |
| $ 19.64M | $ 10.34M | $ -3.23M | $ -14.66M | $ -25.45M | |
| $ 14.30M | $ 7.73M | $ -5.60M | $ -18.63M | $ -27.07M | |
| $ 3.90M | $ 1.13M | $ 661.00K | $ 2.09M | $ -55.00K | |
| $ 18.19M | $ 8.86M | $ -4.94M | $ -16.54M | $ -27.13M | |
| $ 17.38M | $ 8.55M | $ -4.94M | $ -16.54M | $ -27.13M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.22 | $ 0.11 | $ -0.07 | $ -0.24 | $ -0.40 |
| Diluted EPS | $ 0.20 | $ 0.11 | $ -0.07 | $ -0.24 | $ -0.40 |
| Weighted Average Shares Outstanding | 79.18M | 79.72M | 70.54M | 68.92M | 67.19M |
| Weighted Average Shares Outstanding (Diluted) | 85.44M | 79.72M | 74.98M | 69.73M | 67.19M |
Currency in USD